EQRx founder Alexis Borisy (Han jingyu/Imaginechina via AP Images)
Updated: EQRx abandons its mission of drug price reform, will cut more than half of employees
EQRx’s plan to upend the US drug price system with lower-cost treatments is over.
On Monday, it announced a massive strategic reset, slashing its pipeline …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
